SÉZARY

Clinical trials for SÉZARY explained in plain language.

Never miss a new study

Get alerted when new SÉZARY trials appear

Sign up with your email to follow new studies for SÉZARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo therapy tested for Tough-to-Treat skin cancer

Disease control Ongoing

This study is testing whether combining two existing drugs, pembrolizumab and gemcitabine, can help control advanced forms of a rare skin cancer called mycosis fungoides or Sézary syndrome. It is for adults whose disease has worsened after at least one prior treatment. The main g…

Matched conditions: SÉZARY

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

SÉZARY

Get alerted when new SÉZARY trials appear

New combo therapy tested for Tough-to-Treat skin cancer